Intelligence · Clinical Development
Pipeline search results
Programs matching “alzheimer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 141 pipeline programs matching "alzheimer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
63733657EDI1003
Janssen-Cilag International N.V.
Alzheimer's Disease (Healthy Participants)
1 trial -
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants
Merck Sharp and Dohme
Amyotrophic lateral sclerosis and Alzheimer’s disease
1 trial -
A randomised for Depression, Cognitive dysfuncti…
Lacuna Pharma Pty Ltd
Depression, Cognitive dysfunction, Alzheimer’s disease
1 trial -
ACU193
Acumen Pharmaceuticals
Alzheimer Disease
1 trial -
ALN-5288
Alnylam Netherlands B.V.
Alzheimer's Disease
1 trial -
ALN-5288-001
Alnylam Netherlands B.V.
Alzheimer’s Disease
1 trial -
ALN-APP
Alnylam Netherlands B.V.
Early-Onset Alzheimer Disease
1 trial -
ALN-APP-001
Alnylam Netherlands B.V.
Early-onset Alzheimer's disease (EOAD)
1 trial -
BP45211
Hoffmann-La Roche
Alzheimer’s Disease (AD)
1 trial -
CERE-110: Adeno-Associated Virus Delivery of NGF
SANGAMO THERAPEUTICS, INC
Alzheimer's Disease
1 trial -
Characterization of Immune Response in Participants from a Posdinemab Study
Janssen-Cilag International N.V.
Early Alzheimer's disease
1 trial -
DNL628
Denali Therapeutics
Alzheimer Disease, Early Onset
1 trial -
DNL747
Denali Therapeutics
Alzheimer Disease
1 trial -
DNLI-K-0001
Denali Therapeutics
Early Alzheimer's Disease
1 trial -
Donepezil Dihydroxynaphthalate for Injection
Shanghai University of Traditional Chinese Medicine
Alzheimer Disease
1 trial -
First-in-Human Study of RO7812653
Hoffmann-La Roche
Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairment due to AD, or probable AD dementia)
1 trial -
ION269
IONIS PHARMACEUTICALS INC
Alzheimer Disease
1 trial -
ION269-CS1
IONIS PHARMACEUTICALS INC
Alzheimer’s Disease in Individuals with Down Syndrome
1 trial -
IONIS MAPTRx
IONIS PHARMACEUTICALS INC
Mild Alzheimer's Disease
1 trial -
KHK6640
KYOWA KIRIN AUSTRALIA PTY LTD
Alzheimer Disease
1 trial -
KIH24001
The George Institute
Alzheimer´s disease
1 trial -
LX1001
Lexeo Therapeutics
Alzheimer Disease
1 trial -
MP-101-02
Lacuna Pharma Pty Ltd
Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD)
1 trial -
NDX-1017
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.